For lack of rich competition, some of Nvidia's most significant results in the latest MLPerf were against itself, comparing its newest GPU, H100 "Hopper," to its existing product, the A100. Although chip giant Nvidia tends to cast a long shadow over the world of artificial intelligence, its ability to simply drive competition out of the market may be increasing, if the latest benchmark test results are any indication. Did you miss out on Black Friday 2022? No problem: Cyber Monday deals are here, with internet retailers offering their lowest prices of the year. ZDNET is surfacing the latest and best sales online in real time for you to check out now.

We are pleased to announce, thanks to the acquisition of Latham BioPharm Group, we are accelerating in the Life Sciences sector with the creation of a Life Science Consulting division. Latham BioPharm Group founded in 1996 by Peter Latham, is one of the top Life Science Consulting specialty firms supporting Non-Dilutive Funding, Product Development, and Strategic decision-making for a wide range of sectors and clients. "Pete and I have agreed on a global goal, supported by significant financial resources, that will allow us to grow organically at more than 20% per year...." says Matthieu Courtecuisse, Founder and CEO of Sia Partners.

Amazon and One Medical Sign an Agreement for Amazon to Acquire One Medical July 21, 2022 at 8:30 AM EDT Share One Medical is a human-centered, technology-powered U.S. primary care organization on a mission to make quality healthcare more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services One Medical combines in-person care in inviting offices across the country with digital health and virtual care services, making it easier for patients to schedule appointments, renew prescriptions, access up-to-date health records, and advance health outcomes SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--Jul. One Medical is a human-centered, technology-powered national primary care organization on a mission to make quality care more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services that are convenient to where people work, shop, and live.

As many as one in five people age 65 or older experience "mild cognitive impairment" -- a condition marked by a slight decline in memory, language, or thought. Affected individuals may be prone to forgetting appointments or losing the thread of conversations. They also have a higher-than-average risk of developing the more pronounced cognitive decline of Alzheimer's disease. Yet for the majority of people, symptoms do not progress. In fact, in some instances, the symptoms can be temporary or reversible.

The devastating neurodegenerative condition Alzheimer's disease is incurable, but with early detection, patients can seek treatments to slow the disease's progression, before some major symptoms appear. Now, by applying artificial intelligence algorithms to MRI brain scans, researchers have developed a way to automatically distinguish between patients with Alzheimer's and two early forms of dementia that can be precursors to the memory-robbing disease. The researchers, from the VU University Medical Center in Amsterdam, suggest the approach could eventually allow automated screening and assisted diagnosis of various forms of dementia, particularly in centers that lack experienced neuroradiologists. Additionally, the results, published online July 6 in the journal Radiology, show that the new system was able to classify the form of dementia that patients were suffering from, using previously unseen scans, with up to 90 percent accuracy. "The potential is the possibility of screening with these techniques so people at risk can be intercepted before the disease becomes apparent," said Alle Meije Wink, a senior investigator in the center's radiology and nuclear medicine department. "I think very few patients at the moment will trust an outcome predicted by a machine," Wink told Live Science.

The devastating neurodegenerative condition Alzheimer's disease is incurable, but with early detection, patients can seek treatments to slow the disease's progression, before some major symptoms appear. Now, by applying artificial intelligence algorithms to MRI brain scans, researchers have developed a way to automatically distinguish between patients with Alzheimer's and two early forms of dementia that can be precursors to the memory-robbing disease. The researchers, from the VU University Medical Center in Amsterdam, suggest the approach could eventually allow automated screening and assisted diagnosis of various forms of dementia, particularly in centers that lack experienced neuroradiologists. Additionally, the results, published online July 6 in the journal Radiology, show that the new system was able to classify the form of dementia that patients were suffering from, using previously unseen scans, with up to 90 percent accuracy. "The potential is the possibility of screening with these techniques so people at risk can be intercepted before the disease becomes apparent," said Alle Meije Wink, a senior investigator in the center's radiology and nuclear medicine department. "I think very few patients at the moment will trust an outcome predicted by a machine," Wink told Live Science.

The devastating neurodegenerative condition Alzheimer's disease is incurable, but with early detection, patients can seek treatments to slow the disease's progression, before some major symptoms appear. Now, by applying artificial intelligence algorithms to MRI brain scans, researchers have developed a way to automatically distinguish between patients with Alzheimer's and two early forms of dementia that can be precursors to the memory-robbing disease. The researchers, from the VU University Medical Center in Amsterdam, suggest the approach could eventually allow automated screening and assisted diagnosis of various forms of dementia, particularly in centers that lack experienced neuroradiologists. Additionally, the results, published online July 6 in the journal Radiology, show that the new system was able to classify the form of dementia that patients were suffering from, using previously unseen scans, with up to 90 percent accuracy. "The potential is the possibility of screening with these techniques so people at risk can be intercepted before the disease becomes apparent," said Alle Meije Wink, a senior investigator in the center's radiology and nuclear medicine department. "I think very few patients at the moment will trust an outcome predicted by a machine," Wink told Live Science.